Boehringer Ingelheim Venture Fund
Status
ACTIVE
Global HQ
United States
Countries of investment
- Germany
Investment stages
- Seed
- Series A
- Series B
Industries
- Health Tech
- Biotechnology
- AI
- Data Science
About
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Boehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies.
Investment Thesis
The Boehringer Ingelheim Venture Fund invests in pioneering science that offers the potential to provide significant benefits for patients, with investments spanning across various geographies.
Manager's Experience
Backed by extensive experience in venture capital, the fund manager has successfully executed over 50 investments across various sectors, including healthcare, technology, and life sciences. Active primarily in North America and Europe, the investment strategy emphasizes an operator-first approach, allowing for deep engagement with portfolio companies. Notable exits highlight a strong track record of value creation, particularly in early to growth-stage investments. The manager’s thematic focus on innovation and sustainability positions the fund strategically for future opportunities.